U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for 150 million people NEW YORK and MAINZ, GERMANY, February 12, 2021 - Pfizer Inc.(Nasdaq: BNTX)
MAINZ, GERMANY, February 10, 2021 (GLOBE NEWSWIRE) - We started the manufacturing process at the Marburg facility with the execution of the first step: the production of mRNA, which is the active pharmaceutical
Healthcare Contract Manufacturing Market Size Worth $323.6 Billion By 2028: Grand View Research, Inc.
The global healthcare contract manufacturing market
size is expected
to reach USD 323.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected
to expand at a CAGR of 7.7% from 2021 to 2028. The changing regulatory landscape, coupled with rising offshoring to emerging countries, is anticipated to propel the market growth over the forecast period.
Key suggestions from the report:
By type, the pharmaceutical segment dominated the market with a share of 75.2% in 2020 owing to low manufacturing budget and highly sophisticated contract manufacturing service offerings
The medical device type segment is expected to be the fastest-growing segment with a CAGR of 9.7% over the forecast period owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market
(1)
The fully launched MAH and priority review pathways from the NMPA (National Medical Products Administration) is stimulating new demand in China for 2021.
SHANGHAI, Jan. 21, 2021 /PRNewswire/ The recently hosted CPhI & P-MEC China 2020 organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. attracted a remarkable 46,157 visits of professional pharma visitors, including 5,105 international attendees taking part online.
The hybrid event has helped stimulate renewed growth and partnerships across the pharma supply chain, with the pharma industry looking well positioned for 2021. It also provided a welcome glimpse of how returning international pharma events will encourage a boom for the global industry in 2021.